CGEM earnings

14 reported quarters.

Next report expectedComing soon

Scheduled future earnings dates aren't available for this symbol yet. This is a planned addition, not a gap we expect to leave open.

Reported quarters14 quarters


FY2024 Q3	-	-$0.69	-	-	-	-	-
FY2024 Q2	-	-$0.75	-	-	-	-	-
FY2024 Q1	-	-$0.86	-	-	-	-	-
FY2023 Q3	-	-$0.91	-	-	-	-	-
FY2023 Q2	-	-$0.82	-	-	-	-	-
FY2023 Q1	-	-$1.42	-	-	-	-	-
FY2022 Q4	-	-	-	-	0	-	-
FY2022 Q3	-	-$0.54	-	-	0	-	-
FY2022 Q2	-	$3.77	-	-	0	-	-
FY2022 Q1	-	-$0.27	-	-	0	-	-
FY2021 Q4	-	-	-	-	0	-	-
FY2021 Q3	-	-$0.40	-	-	0	-	-
FY2021 Q2	-	-$0.36	-	-	0	-	-
FY2021 Q1	-	-	-	-	18.94M	-	-

Ask about Cullinan Therapeutics, Inc.

The assistant answers from what CGEM has actually filed: 6 annual reports filed with the SEC and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from CGEM's filings and figures. One a day without an account; a free account has its own, and no card.

Follow CGEM from one quarter to the next, not one at a time.

Ten seconds, no card, and nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with CGEM's results

These figures come from the company’s own quarterly SEC filings. The fourth quarter is derived (the annual figure minus the first three) and its EPS is left blank rather than estimated. Past results say nothing about future ones, and none of this is investment advice.